Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2002-03-20
2004-01-06
Kim, Vickie (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S922000, C424S401000
Reexamination Certificate
active
06673842
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to methods of treating onychomycosis employing compositions with urea as the active ingredient. The present invention also finds new uses for urea as an antifungal agent. Onychomycosis refers to a fungal infection of the nail unit, defined as the nail matrix, bed or plate.
BACKGROUND OF THE INVENTION
Urea has been long recognized as a cosmetic ingredient in formulations acting as a humectant and moisturizer. High concentrations of urea, such as 40%, are also known to have mild, antibacterial effect. At these strengths the antibacterial effects are said to be similar to those of antibiotics, with the further advantage that all the common organisms are susceptible and the possibility of resistant strains need not be seriously considered. There have been reports of keratolytic activity attributed to urea with the ability at high concentrations to solubilize and denature protein. Dermatological compositions containing from 21 to 40 wt-% urea for treating dry scaly skin have been described in U.S. Pat. No. 5,919,470.
Concentrated solutions of urea can change the conformation of protein molecules. A striking effect is upon the water-binding capacity of the horny layer of the skin: pieces of normal horny layer, or scales from ichthyotic or psoriatic skin that have been soaked in 30% urea solution take up much more water. This is important because in maintaining the flexibility of the horny layer and the softness of the skin, the water content of the horny layer matters much more than its oil content.
Fungal infections of the nail are notoriously difficult to treat. Traditional, topical therapies cannot penetrate the nail plate, and eradicate the infection in and under the nail bed; they are useful only in milder forms of the disease. Systemic antifungal drug therapy is associated with potentially harmful side effects. Since oral antifungals are distributed throughout the entire body, systemic side effects such as elevated liver enzymes, gastrointestinal disorders and skin rashes are not uncommon and may require expensive medical intervention and laboratory tests.
Topical formulations for treating fungal infections, such as onychomycosis, have recently been described in U.S. Pat. No. 6,281,239B1. The method employs the use of a combination of a known antifungal agent and a tissue softening composition containing 30 to 60 wt-% urea.
SUMMARY OF THE INVENTION
The present invention relates to methods of treating onychomycosis employing compositions containing urea as the antifungal agent. The present invention relates to methods for treating onychomycosis in humans with urea. These methods include topically administrating to the nail area of a human a safe and effective amount of urea. Onychomycosis refers to a fungal infection of the nail unit, defined as the nail matrix, bed or plate.
Accordingly, the present invention is a method for treating onychomycosis by topically administering a safe and effect amount of urea in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4295567 (1981-10-01), Knudsen
patent: 4581351 (1986-04-01), Berke et al.
patent: 5340836 (1994-08-01), Reinhard et al.
patent: 5407958 (1995-04-01), Heath et al.
patent: 5573765 (1996-11-01), Reinhard et al.
patent: 5853732 (1998-12-01), Munden
patent: 5919470 (1999-07-01), Valdez et al.
patent: 6281239 (2001-08-01), Glassman
patent: WO 96/19186 (1996-06-01), None
Aguado et al, Reaggrefation and binding of cell wall proteins from . . . , Database Caplus, AN:1998:463776, abstract, Research Microbiologia, 1998, Vol 149(5), 327-338.*
Friedman-Birnbaum et al., International Journal of Dermatology, 36(1), p 67-69 (abstract), 1977.
Bhagwat Dileep
Glassman Bradley P.
Glassman Daniel
Bradley Pharmaceuticals, Inc.
Covington & Burling
Kim Vickie
Reister Andrea G.
LandOfFree
Method of treating onychomycosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating onychomycosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating onychomycosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3202450